Part of the setup for creating medium density amorphous ice, Christoph Salzmann
A collaboration between scientists at Cambridge and UCL has led to the discovery of a new form of ice that more closely resembles liquid water than any other and may hold the key to understanding this most famous of liquids.
Cambridge Oncology, a new company co-founded by Professor Melinda Duer and James Harrison, CEO of Cycle Pharmaceuticals, is pioneering a new drug that combats cancer tumours by targeting their environment.
The Reisner Lab Outreach Team teach chemistry in an entertaining way, courtesy @ChemistryPhotograph
A group of students recently attended a lecture peppered with fun-filled experiments to illustrate the serious issue of how to combat climate change in an entertaining and informative way.
New DNA sequencing method ‘lifts veil’ from genome black box
Professor Sir Shankar Balasubramanian, courtesy @Chemistry
Many life-saving drugs directly interact with DNA to treat diseases such as cancer, but scientists have struggled to detect how and why they work – until now.
Solar-powered reactor turns plastic and greenhouse gases into sustainable fuels
(Left to right) Erwin Reisner, Subhajit Bhattacharjee, Motiar Rahaman. Taken by Carolina Pulignani.
The Reisner group has developed a solar-powered reactor that converts two distinct waste products; greenhouse gases and plastics, into useful products at the same time.
Join us in person at St Catharine's College, or via a live stream link on YouTube, to hear Dr Peter Wothers discuss how Jane Marcet defied the prejudices of her time and published a book about chemistry for women.
PhD student Alice Merryweather is a member of the Faraday battery project team
A new, low-cost technique for measuring energy storage inside operating batteries should speed up the development of next-generation battery materials.
Learning to use AI to help solve Alzheimer's disease
PhD student Ryan Geiser was inspired to research Alzheimer's disease
Just weeks before losing his grandfather to Alzheimer’s, Ryan Geiser took a genetic test that showed he had a slightly increased risk of developing the same debilitating disease.